tm logo
NMD NEUROMUSCULAR DISORDERS
Live/Registered
REGISTERED

on 23 Jul 2019

Last Applicant/ Owned by

DK-8200 Aarhus N

DK

Serial Number

79238591 filed on 18th May 2018

Registration Number

5809159 registered on 23rd Jul 2019

in the Principal Register

Correspondent Address

Joel D. Leviton

Joel D. Leviton STINSON LLP

MINNEAPOLIS, MN 55402

UNITED STATES

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

NMD NEUROMUSCULAR DISORDERS

Scientific and technological services and research, namely, research in the field of medicine and the development of pharmaceutical preparations; industrial analysis and research services in the field of development of pharmaceutical preparations, and in the field of identification of drug candidates; drug discovery services; basic research and clinical research, hereunder in the field of medicine Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Scientific and technological services and research, namely, research in the field of medicine and the development of pharmaceutical preparations; industrial analysis and research services in the field of development of pharmaceutical preparations, and in the field of identification of drug candidates; drug discovery services; basic research and clinical research, hereunder in the field of medicine and vaccine development; development of medical treatments related to rare and genetic diseases; development of medical treatments related to neurodegenerative diseases; development of medical treatments related to neuromuscular disorders; development of medical treatments that strengthen neuromuscular transmission and muscle function in patients with neuromuscular disorders; development of medical treatments for acute hospital care


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


Chemical-pharmaceutical preparations for the treatment of rare and genetic diseases; chemical-pharmaceutical preparations for the treatment of neurodegenerative diseases; chemical-pharmaceutical preparations for the treatment of neuromuscular disorders; chemical-pharmaceutical preparations that strengthen neuromuscular transmission and muscle function in patients with neuromuscular disorders; chemical-pharmaceutical preparations for the treatment of neuromuscular disorders caused by compromised skeletal muscle excitability; diagnostic preparations for medical purposes; reagents for medical purposes [ and for research ] ; preparations for analysis for medical [ and research ] purposes; pharmaceutical and medical preparations for the treatment of rare and genetic diseases; pharmaceutical and medical preparations for the treatment of neurodegenerative diseases; pharmaceutical and medical preparations for the treatment of neuromuscular disorders; pharmaceutical and medical preparations that strengthen neuromuscular transmission and muscle function in patients with neuromuscular disorders; pharmaceutical and medical preparations for acute hospital care, namely, chemical-pharmaceutical preparations for the reversal of neuromuscular blockade, chemical-pharmaceutical preparations for the treatment of intensive care unit acquired muscle weakness, chemical-pharmaceutical preparations for the treatment of neuromuscular disorders caused by infections


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 79238591

Mark Type

No Service Mark

Attorney Docket Number

No 3515677-0002

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Design Code(s)

26.07.21 -

Diamonds that are completely or partially shaded

26.17.01 -

Straight line(s), band(s) or bar(s)

26.17.04 -

Vertical line(s), band(s) or bar(s)

Legal History


Show more

Status DateAction Taken
23rd Jul 2024COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
09th Sep 2023CHANGE OF NAME/ADDRESS REC'D FROM IB
29th Aug 2020INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
26th Jul 2020PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
06th Dec 2019FINAL DECISION TRANSACTION PROCESSED BY IB
21st Nov 2019CORRECTION UNDER SECTION 7 - PROCESSED
21st Nov 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
14th Nov 2019FINAL DISPOSITION NOTICE SENT TO IB
14th Nov 2019LIMITATION FROM THE IB EXAMINED AND ENTERED
14th Nov 2019FINAL DISPOSITION PROCESSED